abstract |
Pharmaceutical compounds and compositions containing these compounds, which inhibit the activity of histone deacetylase 8 (HDAC8), are described herein. Methods for using these HDAC8 inhibitors, alone or in combination with other compounds, to treat diseases or conditions that would benefit from inhibition of HDAC8 activity are also described. |